Inc.

2025 COA 85
CourtColorado Court of Appeals
DecidedOctober 30, 2025
Docket24CA1393
StatusPublished
Cited by1 cases

This text of 2025 COA 85 (Inc.) is published on Counsel Stack Legal Research, covering Colorado Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Inc., 2025 COA 85 (Colo. Ct. App. 2025).

Opinion

The summaries of the Colorado Court of Appeals published opinions constitute no part of the opinion of the division but have been prepared by the division for the convenience of the reader. The summaries may not be cited or relied upon as they are not the official language of the division. Any discrepancy between the language in the summary and in the opinion should be resolved in favor of the language in the opinion.

SUMMARY October 30, 2025

2025COA85

No. 24CA1393 Smith v. Terumo BCT, Inc. — Class Actions; Courts and Court Procedure — Jurisdiction of Courts — Standing — Injury in Fact

A division of the court of appeals holds that a plaintiff cannot

establish standing to sue based solely on an allegation that the

defendant’s negligent conduct may increase his future risk of illness

or injury. The concurrence dubitante raises questions about the

correct interpretation of C.R.C.P. 60(b)(5) in the wake of seemingly

conflicting decisions in Schaden v. DIA Brewing Co., 2021 CO 4M,

and BLOM Bank SAL v. Honickman, 605 U.S. 204, 214 (2025). COLORADO COURT OF APPEALS 2025COA85

Court of Appeals No. 24CA1393 Jefferson County District Court No. 19CV31822 Honorable Lindsay VanGilder, Judge

Edward Smith, Jr.,

Plaintiff-Appellant,

and

Paula Jensen and Gay Lang,

Intervenors-Appellants

v.

Terumo BCT, Inc., and Terumo BCT Sterilization Services, Inc.,

Defendants-Appellees.

JUDGMENT AFFIRMED

Division V Opinion by JUDGE GROVE Welling and Johnson, JJ., concur Grove, J., concurs dubitante

Announced October 30, 2025

Singleton Schreiber LLP, Kevin S. Hannon, Yohania T. Santana, Denver, Colorado, for Plaintiff-Appellant and Intervenors-Appellants

McFarland Litigation Partners, LLC, J. Lucas McFarland, Golden, Colorado; King & Spalding LLP, Paul Alessio Mezzina, Nicolas A. Mecsas-Faxon, Washington, D.C.; King & Spalding LLP, Douglas A. Henderson, Nicholas H. Howell, Atlanta, Georgia, for Defendants-Appellees Wheeler Trigg O’Donnell, LLP, Frederick R. Yarger, Kate K. Fletcher, Denver, Colorado, for Amici Curiae American Property Casualty Insurance Association, Advanced Medical Technology Association, National Federation of Independent Business Small Business Legal Center, Inc., American Tort Reform Association, Chamber of Commerce of the United States of America, Colorado Chamber of Commerce, Coalition for Litigation Justice, Inc., and American Coatings Association ¶1 In Colorado, a plaintiff must satisfy two criteria to establish

standing to sue: (1) an injury in fact to (2) a legally protected

interest. Ainscough v. Owens, 90 P.3d 851, 856 (Colo. 2004). In

this case, we consider whether Edward Smith, Jr., the named

plaintiff in this putative class action lawsuit, adequately pleaded

that he suffered an injury in fact by alleging that he and other class

members have been exposed to and absorbed toxic chemicals from

nearby industrial facilities. The district court concluded that

Smith’s complaint must be dismissed because it did not allege that

Smith and his fellow class members have fallen ill or suffered any

other tangible adverse effects as a result of their alleged chemical

exposure. It thus denied Smith’s motion to amend his complaint

under C.R.C.P. 15(a), his motion for relief and subsequent leave to

amend under C.R.C.P. 60(b)(5), and a motion by Paula Jensen and

Gay Lang to intervene as plaintiffs under C.R.C.P. 24(a) or (b).

¶2 Like the district court, we conclude that a plaintiff cannot

establish standing to sue under Colorado law based solely on an

allegation that the defendant’s actions have increased the plaintiff’s

risk of future illness or disease. Therefore, we affirm.

1 I. Background

¶3 We draw the following factual background from Smith’s

complaint and the proposed amended complaint.

¶4 Defendants, Terumo BCT, Inc., and Terumo BCT Sterilization

Services, Inc. (collectively, Terumo), are the owners and operators of

manufacturing and sterilization facilities in Lakewood. Terumo

sterilizes medical equipment using ethylene oxide (EtO), which is a

colorless and odorless gas and a known carcinogen. The Lakewood

facilities emit EtO in accordance with an air quality permit issued

by the Colorado Department of Public Health and Environment.

¶5 In December 2019, Smith filed a class action lawsuit on behalf

of himself and other similarly situated residents living near the

Lakewood facilities. In his complaint, Smith asserted claims for

negligence, strict liability for ultrahazardous activity, private

nuisance, and public nuisance. He alleged that he and other class

members have been injured because they have been exposed to

large amounts of EtO emissions from the Lakewood facilities since

1988.

¶6 Smith did not allege that he or any other member of the

proposed class has suffered any adverse physical effects from EtO

2 exposure; to the contrary, he excluded from the proposed class “all

persons who have been diagnosed with cancer related to exposure

to EtO.” As for the injuries suffered by members of the proposed

class, Smith alleged that the “significant exposure” he and other

nearby residents have experienced has increased their “risk of

illness, disease process and/or disease, including cancer.” An

appropriate remedy for this “increased risk,” Smith contended,

would be to award him and other class members “the cost of a

program of diagnostic testing for the early detection of illnesses,

disease processes or disease” to ensure that any illnesses caused by

EtO exposure could be “immediately identified and aggressively

treated.”

¶7 Terumo moved to dismiss Smith’s complaint. The district

court granted the motion, reasoning that Smith had not alleged that

he or any other class member has been injured by EtO exposure.

As the court put it, “[e]ven taking [Smith’s] allegations of exposure

and heightened risk of developing disease as true, the Court finds

exposure to a toxic substance does not, by itself, establish injury for

an action in tort.”

3 ¶8 The court dismissed the complaint on February 16, 2021.

Although the order did not indicate whether the dismissal was with

or without prejudice, the register of actions includes two additional

entries on the same date, one stating that the case was dismissed

without prejudice and the other stating that the case was

administratively closed.

¶9 Smith did not appeal the district court’s February 16, 2021,

order. Instead, on April 5, 2021, he filed a motion to amend the

complaint under C.R.C.P. 15(a) or, alternatively, for relief from

judgment under C.R.C.P. 60(b)(5).1 The proposed amended

complaint sought to add two plaintiffs — Jensen and Lang — who

at the same time moved to intervene in the case. It also alleged

additional facts about EtO’s hazardous, mutagenic, cancer-causing,

and genotoxic nature; diagnostic testing and monitoring available to

facilitate early detection of diseases associated with EtO exposure;

1 At the end of his response to Terumo’s motion to dismiss, Smith

requested “leave to amend his complaint if the Court cannot deny Defendants’ [C.R.C.P.] 12(b)(5) motion.” The court did not address Smith’s request at the time because, as the court noted in a subsequent order, it was not submitted as a separate motion. See C.R.C.P. 121, § 1-15(1)(d) (“A motion shall not be included in a response or reply to the original motion.”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

US Bank v. 355 Lake
Colorado Court of Appeals, 2025

Cite This Page — Counsel Stack

Bluebook (online)
2025 COA 85, Counsel Stack Legal Research, https://law.counselstack.com/opinion/inc-coloctapp-2025.